pharma · Hypertriglyceridemia · Type 2 Diabetes Mellitus · IONS
IONIS PHARMACEUTICALS
IONIS PHARMACEUTICALS INC
IONIS PHARMACEUTICALS is a pharma organization headquartered in Carlsbad, USA. It trades on NYSE under ticker IONS. Primary therapeutic focus areas include Hypertriglyceridemia, Type 2 Diabetes Mellitus, Familial Chylomi
2855 Gazelle Ct, Carlsbad, CA 92010, US HQ
1989 Founded
1,493 Employees
Public company Type
IONS · NYSE Ticker
Company details
- Status
- Public
- HQ
- 2855 Gazelle Ct, Carlsbad, CA 92010, US
- Founded
- 1989
- Employees
- 1,493
- Programs
- 128
- Drugs
- 48
- Patents
- 222
Eplontersen
Phase 3 · small molecule · Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
Eplontersen for Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) is a Phase 3 program (small_molecule) at IONIS PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).
Internal code ION-682884-CS2
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- IONIS PHARMACEUTICALS INC
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
- Status
- active
- Trials
- 2